Form 4: Immunocore Holdings Director Acquires Shares Through Option Award
SEC Form 4 Filing
Kristine Peterson, a director at Immunocore Holdings plc, acquired 14,534 shares through a share option award on May 23, 2024.
Summary
- On May 23, 2024, Kristine Peterson, a director of Immunocore Holdings plc, acquired 14,534 shares through a share option award.
- The exercise price of the share option is $50.47.
- The shares will vest on the earlier of May 23, 2025, or the day before the next annual general meeting, contingent upon continuous service.
- The option expires on May 22, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction with a potential positive signal due to a director increasing their stake in the company.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The vesting of the options is contingent upon the director's continuous service, aligning her interests with the long-term success of the company.
Industry Context
This transaction is a routine disclosure of insider activity, common among publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of the share option award transaction. |
| 05/23/2025 | Earliest vesting date for the share options. |
| 05/22/2034 | Expiration date of the share options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.